Company Data

Kiniksa Pharmaceuticals Ltd.

Ticker
KNSA
Current Price
$27.63 4.3%
Market Cap
$2.0B
Price Target
Refer to Report
Volume
438.0K
52wk Range
$17.38 - $28.56
Advanced Market Data

Overview

Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. Its clinical-stage product candidates include Rilonacept, for the treatment of recurrent pericarditis, a debilitating inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody for the treatment of giant cell arteritis; Vixarelimab; and KPL-404.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy